Number of the records: 1  

Anti-apoptotic MCL1 Protein Represents Critical Survival Molecule for Most Burkitt Lymphomas and BCL2-negative Diffuse Large B-cell Lymphomas

  1. 1.
    SYSNO0554659
    TitleAnti-apoptotic MCL1 Protein Represents Critical Survival Molecule for Most Burkitt Lymphomas and BCL2-negative Diffuse Large B-cell Lymphomas
    Author(s) Klánová, M. (CZ)
    Kazantsev, D. (CZ)
    Pokorná, E. (CZ)
    Zikmund, T. (CZ)
    Karolová, J. (CZ)
    Behounek, M. (CZ)
    Renesova, N. (CZ)
    Sovilj, Dana (BTO-N) RID, ORCID
    Kelemen, Cristina D. (BTO-N) RID, ORCID
    Helman, K. (CZ)
    Jaksa, R. (CZ)
    Havranek, O. (CZ)
    Anděra, Ladislav (BTO-N) ORCID, RID
    Trněný, M. (CZ)
    Klener, P. (CZ)
    Corespondence/seniorKlener, P. - Korespondující autor
    Source Title Molecular Cancer Therapeutics. Roč. 21, č. 1 (2022), s. 89-99. - : American Association for Cancer Research
    Document TypeČlánek v odborném periodiku
    Grant GA19-08772S GA ČR - Czech Science Foundation (CSF), CZ - Czech Republic
    NU21-03-00386 GA MZd - Ministry of Health (MZ), CZ - Czech Republic
    Institutional supportBTO-N - RVO:86652036
    Languageeng
    CountryUS
    Keywords gene-expression * elderly-patients * bcl-2 family * venetoclax * chemotherapy
    Cooperating institutions Charles Univ Prague, Fac Med 1, Inst Pathol Physiol, Prague, Czech Republic
    Charles Univ Gen Hosp, Dept Med 1, Dept Hematol, Prague, Czech Republic
    Charles Univ Prague, Fac Med 1, BIOCEV, Prague, Czech Republic
    Helmholtz Ctr Munich, Inst Epigenet & Stem Cells, Munich, Germany
    Inst Biotechnol CAS BIOCEV, Vestec, Czech Republic
    Prague Univ Econ & Business, Prague, Czech Republic
    Charles Univ Gen Hosp, Inst Pathol, Prague, Czech Republic
    Inst Mol Genet CAS, Prague, Czech Republic
    URLhttps://aacrjournals.org/mct/article/21/1/89/675161/Anti-apoptotic-MCL1-Protein-Represents-Critical
    Permanent Linkhttp://hdl.handle.net/11104/0331895
     
Number of the records: 1  

  This site uses cookies to make them easier to browse. Learn more about how we use cookies.